Neuronetics (STIM) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 11.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.43% |
| Dec 31, 2025 | 39.84% |
| Sep 30, 2025 | -2.13% |
| Jun 30, 2025 | 4.37% |
| Mar 31, 2025 | -46.39% |
| Dec 31, 2024 | -110.96% |
| Sep 30, 2024 | 7.23% |
| Jun 30, 2024 | -23.45% |
| Mar 31, 2024 | 21.10% |
| Dec 31, 2023 | 28.96% |
| Sep 30, 2023 | -20.36% |
| Jun 30, 2023 | 19.85% |
| Mar 31, 2023 | 0.95% |
| Dec 31, 2022 | -10.71% |
| Sep 30, 2022 | -2.19% |
| Jun 30, 2022 | -40.51% |
| Mar 31, 2022 | -40.78% |
| Dec 31, 2021 | -117.19% |
| Sep 30, 2021 | -138.62% |
| Jun 30, 2021 | 3.88% |
| Mar 31, 2021 | 32.91% |
| Dec 31, 2020 | 53.20% |
| Sep 30, 2020 | 52.80% |
| Jun 30, 2020 | -4.07% |
| Mar 31, 2020 | -47.54% |
| Dec 31, 2019 | -18.85% |
| Sep 30, 2019 | -37.98% |
| Jun 30, 2019 | -22.85% |
| Mar 31, 2019 | -44.32% |
| Dec 31, 2018 | -32.72% |
| Sep 30, 2018 | -45.42% |
| Jun 30, 2018 | -86.62% |
| Mar 31, 2018 | -21.77% |